Question · asked by 1 review
Aspirin vs vitamin K antagonist (VKA): Minor bleeding ‐ not reported
- Population
- ambulatory patients with multiple myeloma receiving immunomodulatory agents
- Intervention
- Aspirin
- Comparison
- vitamin K antagonist (VKA)
- Outcome
- Minor bleeding ‐ not reported
The review found no eligible studies for this question.
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Aspirin (ASA) vs vitamin K antagonist (VKA) Minor bleeding ‐ not reported · ambulatory patients with multiple myeloma receiving immunomodulatory agents The review found no eligible studies for this question. Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents (2021) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents 2021 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Aspirin vs low molecular weight heparin · ambulatory patients with multiple myeloma receiving immunomodulatory agents · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.